e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diagnosis and management of pleural and mediastinal diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Over-expression of chloride intracellular channels (CLICs) 3 and 4 in malignant pleural mesothelioma
V. Tasiopoulou, I. Lempesis, D. Magouliotis, R. Jagirdar, E. Solenov, C. Hatzoglou, P. A. Molyvdas, K. Gourgoulianis, S. Zarogiannis (Larissa, Novosibirsk, Greece)
Source:
Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Session:
Diagnosis and management of pleural and mediastinal diseases
Session type:
Thematic Poster Session
Number:
2927
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Tasiopoulou, I. Lempesis, D. Magouliotis, R. Jagirdar, E. Solenov, C. Hatzoglou, P. A. Molyvdas, K. Gourgoulianis, S. Zarogiannis (Larissa, Novosibirsk, Greece). Over-expression of chloride intracellular channels (CLICs) 3 and 4 in malignant pleural mesothelioma. Eur Respir J 2013; 42: Suppl. 57, 2927
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Asbestosis
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Diagnosis and staging of malignant pleural mesothelioma
Related content which might interest you:
Differential gene expression of two-pore-domain potassium channels in malignant pleural mesothelioma
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
Effect of asbestos on gene expression of tight junctions components in malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
beta1 and beta2 adrenergic receptors are significantly under-expressed in malignant pleural mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Activated KRAS signaling triggers malignant pleural effusion
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
The role of Epithelial sodium channel (ENaC) in cell proliferation and tunneling nanotube (TnT) formation in benign mesothelial cells and malignant pleural mesothelioma (MPM) cells.
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: In-vitro study
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
The role of aquaporin-1 (AQP1) and amiloride sensitive epithelial sodium (ENaC) in cell adhesion of mesothelioma cells is cell and extracellular matrix type dependent
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
The role of amiloride sensitive epithelial sodium channel (ENaC) in cell migration of mesothelioma cells is dependent on the cell type and the extracellular matrix
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Role of tumor derived versican in experimental malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016
Hypertonicity increases apparent water permeability in benign mesothelial cells but differentially regulates it in epithelioid mesothelioma cells depending on the osmotic agent
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Volume quantification of malignant pleural mesothelioma
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
High fluorescence cells in pleural fluid. Association with pleural malignancy
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Malignant pleural mesothelioma (MPM) – 5 years of experience
Source: Eur Respir J 2006; 28: Suppl. 50, 91s
Year: 2006
Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Survival analysis of pleural malignant mesothelioma (MM) at a single Institution in Liguria, Italy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Tumour marker (TM) CA 19-9 in pleural fluid at patients with malignant and paramalignant pleural effusion (PE)
Source: Eur Respir J 2001; 18: Suppl. 33, 387s
Year: 2001
Malignant mesothelioma vs metastatic carcinoma of pleura: Do pathology and radiology agree?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013
Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept